Global Allergy Immunotherapy (AIT) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)
- Report Description Table of Contents
Scope of the Report
The report titled “Global Allergy Immunotherapy (AIT) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)”, provides an in depth analysis of the global allergy immunotherapy market by value, by method of administration, by allergy type, by distribution channel, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including the following regions: Europe (Germany, France, UK, Italy, Spain and Rest of Europe), the US, and Rest of the World. The report also provides a detailed analysis of the COVID-19 impact on the allergy immunotherapy market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global allergy immunotherapy market is dominated with few major market players operating worldwide. The key players of the allergy immunotherapy market are Allergy Therapeutics PLC, ALK-Abelló A/S, Dermapharm Holding SE (Allergopharma GmbH & Co. KG), and Stallergenes Greer are also profiled with their financial information and respective business strategies.
- The US
- Rest of the World
- Allergy Therapeutics PLC
- ALK-Abelló A/S
- Dermapharm Holding SE (Allergopharma GmbH & Co. KG)
- Stallergenes Greer
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Immunotherapy involves exposing people to larger and larger amounts of allergen in an affect to change the immune system's response. Allergy immunotherapy is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. The allergy immunotherapy can be classified on the basis of method of administration: subcutaneous (SCIT), sublingual (SLIT-tablets/drops) and whole allergen.
The allergy immunotherapy market can be segmented on the basis of method of administration; allergy type; and distribution channel.
The global allergy immunotherapy market has increased at a significant CAGR during the years 2015-2019 and projections are made that the market would rise in the next four years i.e. 2020-2024 tremendously. The allergy immunotherapy market is expected to increase due to increasing level of air pollution, growing industrial activities, escalating healthcare spending, rapid urbanization, rising prevalence of allergic diseases, etc. Yet the market faces some challenges such as high cost involved, side effects associated with allergy immunotherapy, etc.